[an error occurred while processing this directive]



 
    § 241. Definitions. For purposes of this title, the terms:
    * 1.  "Covered  drug" shall mean a drug dispensed subject to a legally
  authorized prescription pursuant to section sixty-eight hundred  ten  of
  the  education  law,  and  insulin,  an  insulin  syringe, or an insulin
  needle. Such term shall not include: (a)  any  drug  determined  by  the
  commissioner   of  the  federal  food  and  drug  administration  to  be
  ineffective or unsafe; (b) any drug dispensed in a package, or  form  of
  dosage or administration, as to which the commissioner of health finally
  determines  in  accordance  with  the  provisions of section two hundred
  fifty-two of this title that a less expensive package, or form of dosage
  or administration, is available that is pharmaceutically equivalent  and
  equivalent   in   its   therapeutic   effect   for  the  general  health
  characteristics of the eligible program participant population; (c)  any
  device  for  the  aid  or  correction of vision; (d) any drug, including
  vitamins,  which  is   generally   available   without   a   physician's
  prescription;  and  (e)  drugs  for  the treatment of sexual or erectile
  dysfunction, unless such drugs are used to treat a condition, other than
  sexual or erectile dysfunction, for which the drugs have  been  approved
  by the federal food and drug administration. Any of the drugs enumerated
  in  the  preceding  sentence  shall  be  considered  a covered drug or a
  prescription drug for purposes of this article if it  is  added  to  the
  preferred  drug  list  under article two-A of the public health law. For
  the purpose of this title, except as otherwise provided in this section,
  a covered drug shall be dispensed in quantities no greater than a thirty
  day supply or one hundred units, whichever is greater. In the case of  a
  drug  dispensed  in  a  form  of  administration  other than a tablet or
  capsule, the maximum allowed quantity shall be a thirty day supply;  the
  panel  is  authorized to approve exceptions to these limits for specific
  products following consideration of recommendations from  pharmaceutical
  or medical experts regarding commonly packaged quantities, unusual forms
  of  administration,  length  of  treatment or cost effectiveness. In the
  case of a drug  prescribed  pursuant  to  section  thirty-three  hundred
  thirty-two  of the public health law to treat one of the conditions that
  have  been  enumerated  by  the  commissioner  of  health  pursuant   to
  regulation  as  warranting  the prescribing of greater than a thirty day
  supply, such drug shall be dispensed in quantities not to exceed a three
  month supply.
    * NB Effective until June 15, 2012
    * 1. "Covered drug" shall mean a drug dispensed subject to  a  legally
  authorized  prescription  pursuant to section sixty-eight hundred ten of
  the education law, and  insulin,  an  insulin  syringe,  or  an  insulin
  needle.  Such  term  shall  not  include: (a) any drug determined by the
  commissioner  of  the  federal  food  and  drug  administration  to   be
  ineffective  or  unsafe; (b) any drug dispensed in a package, or form of
  dosage or administration, as to which the commissioner of health finally
  determines in accordance with the  provisions  of  section  two  hundred
  fifty-two of this title that a less expensive package, or form of dosage
  or  administration, is available that is pharmaceutically equivalent and
  equivalent  in  its  therapeutic   effect   for   the   general   health
  characteristics  of the eligible program participant population; (c) any
  device for the aid or correction  of  vision,  or  any  drug,  including
  vitamins,   which   is   generally   available   without  a  physician's
  prescription; and (d) drugs for the  treatment  of  sexual  or  erectile
  dysfunction, unless such drugs are used to treat a condition, other than
  sexual  or  erectile dysfunction, for which the drugs have been approved
  by the federal food and drug administration. For  the  purpose  of  this
  title,  except  as  otherwise  provided  in this section, a covered drug
  shall be dispensed in quantities no greater than a thirty day supply  or
  one hundred units, whichever is greater. In the case of a drug dispensed
  in  a form of administration other than a tablet or capsule, the maximum
  allowed quantity shall be a thirty day supply; the panel  is  authorized
  to  approve  exceptions  to these limits for specific products following
  consideration of recommendations from pharmaceutical or medical  experts
  regarding commonly packaged quantities, unusual forms of administration,
  length  of  treatment  or  cost  effectiveness.  In  the  case of a drug
  prescribed pursuant to section thirty-three hundred  thirty-two  of  the
  public  health  law  to  treat  one  of  the  conditions  that have been
  enumerated by the commissioner  of  health  pursuant  to  regulation  as
  warranting  the  prescribing  of  greater than a thirty day supply, such
  drug shall be dispensed in  quantities  not  to  exceed  a  three  month
  supply.
    * NB Effective June 15, 2012
    2.  "Provider  pharmacy" shall mean a pharmacy registered in the state
  of New York  pursuant  to  section  sixty-eight  hundred  eight  of  the
  education law or a pharmacy registered in a state bordering the state of
  New  York when certified as necessary by the executive director pursuant
  to section two hundred fifty-three of this title, for which an agreement
  to provide pharmacy services for purposes of this  program  pursuant  to
  section two hundred forty-nine of this title is in effect.
    3. "Income" shall mean "household gross income" as defined in the real
  property  tax  circuit  breaker credit program, pursuant to subparagraph
  (C) of paragraph one of subsection (e) of section six hundred six of the
  tax law, but only shall include the income  of  program  applicants  and
  spouses and shall exclude the income of other members of the household.
    4.  "Contractor"  shall  mean  a private not-for-profit or proprietary
  corporation which has entered into a contractual  arrangement  with  the
  state  to carry out the provisions of section two hundred forty-three of
  this title.
    5. "Resident" shall mean an individual legally  domiciled  within  the
  state.
    6.   "Annual   coverage  period"  shall  mean  the  period  of  twelve
  consecutive calendar months for which an  eligible  program  participant
  has  met the application fee or deductible requirements, as the case may
  be, of sections two hundred forty-seven and two hundred  forty-eight  of
  this title.
    7.  "Program  year"  shall  mean a year beginning on October first and
  ending the following September thirtieth.

Last modified: November 19, 2006